Cynosure Completes Very Successful IPO

Cynosure Completes Very Successful IPO

Firm News

Cynosure (Nasdaq: CYNO) closed a very successful IPO on December 14 to cap off the 2005 IPO season during which WilmerHale handled 11 IPOs — eight as issuer counsel and three as underwriter counsel — in the US and Europe.

Cynosure develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions and temporarily reduce the appearance of cellulite. Cynosure’s IPO, which raised $86,250,000, was priced above the estimated price range at $15 per share and has traded up 25-50% since.

Serving as Cynosure’s counsel in the IPO were WilmerHale lawyers David Redlick, David Westenberg, Corey DuFresne, Jason Kropp and Dana Krueger.

WilmerHale’s other IPOs in 2005 were:

  • Gas Turbine Efficiency (LSE: GTE) — £5,400,000 — Counsel to Issuer
  • Icagen (Nasdaq: ICGN) — $40,000,000 — Counsel to Issuer
  • IRobot (Nasdaq: IRBT) — $118,680,000 — Counsel to Underwriters
  • NxStage Medical (Nasdaq: NXTM) — $63,250,000 — Counsel to Issuer
  • Speedel Holding (SWX: SPPN) — SWX Exchange — Counsel to Issuer
  • SPI Lasers (LSE: SPIL) — £12,000,000 — Counsel to Issuer
  • SSA Global Technologies (Nasdaq: SSAG) — $113,850,000 — Counsel to Underwriters
  • Unica (Nasdaq: UNCA) — $55,200,000 — Counsel to Issuer
  • VistaPrint (Nasdaq: VPRT) — $138,220,000 — Counsel to Issuer
  • Website Pros (Nasdaq: WSPI) — $68,000,000 — Counsel to Underwriters

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link. (The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.